Comparison of Vascular Access for Radial and Femoral Completion of Diagnostic Cardiac Catheterization (COMPACT)

November 14, 2013 updated by: Celin Malkun, Centro Cardiológico del Caribe, Columbia

Comparison of Vascular ACcess for Radial and Femoral Completion of Diagnostic Cardiac Catheterization Performed at the Clinic Patients Northern General de Barranquilla in 2013. Controlled Clinical Trial of Non-inferiority

Cardiac catheterization is the most important test for the evaluation of cardiac patients. Since the beginning of the cardiac catheterization procedure, we have used the femoral artery puncture as a gateway for those procedures. Recently it is used more often the path for the radial. Using this approach has gained many followers worldwide and has been used almost routinely in our country but has not gained popularity because many interventional cardiologists argue that the transradial procedure is much more time-consuming and difficult.

Research question: Are there differences in the total procedure time path between radial and femoral vascular to perform cardiac catheterizations?.

This research focuses on the search for information to determine whether there are significant differences when the variables under study. This research is justified by the need to evaluate the two techniques in use and the lack of studies evaluating and comparing the radial arterial access in comparison with femoral access route which is widely used in all services hemodynamics national and international. The lack of research on the subject has made the use of the transradial procedure routinely not being done, because they have the idea that it is much more time-consuming and technically more difficult than the procedure performed by the femoral approach, hence Hemodynamics specialists, not everyone wants to start implementing the systematic use of the radial approach for cardiac catheterization studies.The main objective of this project is to determine the non-inferiority in terms of total procedure time path between radial and femoral vascular to perform cardiac catheterizations. Secondary objectives: the difference in time of puncture, duration of the procedure and recovery. Incidence of vascular complications and techniques between radial and femoral, presence of complications at 8 days of follow-up. Our aims to check through the results, if the difference in each of the variables favoring either of the two techniques and to determine the non-inferiority of one technique over the other in terms of ease and effectiveness of both procedures. The type of study is a controlled clinical trial open, randomized, non-inferiority. The study population will consist of patients who have been told the diagnostic cardiac catheterization, they are sent to the General Clinic Northern institution.

Study Overview

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Atlco
      • Barranquilla, Atlco, Colombia, NT
        • Clínica General del Norte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients over 18 years
  • Patients requiring a performing diagnostic cardiac catheterization procedure, scheduled electively or urgently,
  • Patients mentally healthy
  • Patients with test Allen (palmar arch patency) normal
  • Patients who signing the informed consent.

Exclusion Criteria:

  • Patients with a history of allergic reaction to the dye.
  • Patients with peripheral vascular disease.
  • Anticoagulated patients with coumarinic or other oral anticoagulants.
  • Patients with arteriovenous fistula for hemodialysis.
  • Patients with a history of coronary artery bypass surgery.
  • Patients with amputations or upper limb deformities.
  • Patients with limited movement in the upper limbs or burns contractures.
  • Patients requiring catheterization while the right heart do.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Radial Technical
Radial technical is the procedure for catheterization
Vascular Access for cardiac catheterization
Other Names:
  • Iohexol
Active Comparator: Femoral Technical
Vascular Access for cardiac catheterization
Other Names:
  • Iohexol
Vascular Access for cardiac catheterization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minutes Total Procedure Time
Time Frame: Assess the total duration of the procedure in minutes. Up to 15 min
The primary outcome measure in this trial, is the time in minutes spent on the realization of the entire cardiac catheterization procedure
Assess the total duration of the procedure in minutes. Up to 15 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minute of Fluoroscopic time
Time Frame: Assess the total duration of the procedure in minutes. Up to 5 min
This secindary outcome is the time in minutes spent during fluoroscopy
Assess the total duration of the procedure in minutes. Up to 5 min

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: 8 days
Vascular and Clinical complications
8 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Celin Malkun, MD, MSc, Centro Cardiológico del Caribe, Columbia
  • Study Director: Jorge Luis Acosta, MD, MSc, Universidad del Norte, Barranquilla, Colombia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

October 25, 2013

First Submitted That Met QC Criteria

November 7, 2013

First Posted (Estimate)

November 14, 2013

Study Record Updates

Last Update Posted (Estimate)

November 15, 2013

Last Update Submitted That Met QC Criteria

November 14, 2013

Last Verified

November 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Heart Diseases

Clinical Trials on Radial Technical

Subscribe